Alex: three months of CAR-T care in Beijing, from 60 e-mails to a fridge magnet

Patient from

Not disclosed

Alex (pseudonym)

45 years old; home country not disclosed

Condition

Relapsed multiple myeloma

Treatment

CAR-T cell therapy

Hospital

Beijing United Family Hospital

City

Beijing

Before China

Diagnosed in April 2022, Alex had several lines of chemotherapy and targeted therapy at home and reached remission twice, but the cancer relapsed in November 2025 and his doctors had no further effective options. CAR-T was not yet commercially available in his country, and in the U.S. it came with a long waiting list.

Getting care in China

Referred by his own doctor to the hematology team at United Family in Beijing, he received about 60 e-mails over nearly three weeks, a virtual tour of the hospital and full help with the medical visa. He and his family arrived on 26 December 2025; staff helped with a local SIM card, nearby accommodation, food shopping and cross-border money transfers.

Timeline

1. 1April 2022Diagnosed with multiple myeloma; two remissions on treatment at home.
2. 2November 2025Relapse; local doctors have no further effective options.
3. 3December 26, 2025Arrives in Beijing with his family after about 60 e-mails and a virtual hospital tour.
4. 4March 28, 2026Completes more than three months of treatment and flies home.

Outcome

After a treatment stay of more than three months he left hospital and flew home on 28 March 2026. The Global Times described him as gradually recovering to good health. He said he would recommend Chinese healthcare to fellow patients.

Each story is one person’s reported experience, not a promise of results. Outcomes differ with diagnosis and the individual. This is not medical advice; treatment decisions are made with the treating hospital.